课题基金 / 基金详情

CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia

CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia
HIV-1 痴呆中 CXCL8 介导的神经胶质串扰和神经保护
批准号:
7886747
负责人:
Anuja Ghorpade
金额:
$36.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2014-07-31
关键词:
AIDS Dementia ComplexAbbreviationsAcquired Immunodeficiency SyndromeAddressAgeAlzheimer&aposs DiseaseAnti-Retroviral AgentsApoptosisAreaAsthmaAstrocytesBasal GangliaBiochemicalBiologicalBiologyBlood - brain barrier anatomyBrainBromidesCD40 LigandCell SurvivalCellsCentral Nervous System InfectionsCerebrospinal FluidChronic Obstructive Airway DiseaseCoculture TechniquesComplicationConsultationsDNA NucleotidylexotransferaseDataData AnalysesDementiaDevelopmentDigoxigeninDiseaseDominant-Negative MutationDoseEncephalitisEventExtracellular Signal Regulated KinasesG Protein-Coupled Receptor GenesG-Protein-Coupled ReceptorsGenesGlial Fibrillary Acidic ProteinHIVHIV encephalitisHIV-1Highly Active Antiretroviral TherapyHumanIL8 geneIL8RA geneIL8RB geneImmuneImmune responseImpairmentIn SituIn Situ Nick-End LabelingInfectionInflammationInflammatoryInflammatory ResponseInstitutionInterferonsInterleukin 8A ReceptorInterleukin-12Interleukin-8B ReceptorInterleukinsInvestigationKineticsLabelLaboratoriesLactate DehydrogenaseLeadLettersLifeLinkLiteratureMalignant NeoplasmsMediatingMediator of activation proteinMicrogliaMicroscopicMicrotubule-Associated ProteinsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesMolecularMononuclearN-MethylaspartateNeuraxisNeurocognitiveNeurodegenerative DisordersNeurogliaNeurologicNeuronal InjuryNeuronsNeuropathogenesisNeurotoxinsNuclearOutcomePTPN11 genePathway AnalysisPathway interactionsPatientsPeripheral Blood Mononuclear CellPhagocytesPhosphatidylinositolsPhosphorylationPlatelet Activating FactorPlayPrevalenceProcessProductionProtein Kinase CProtein Tyrosine PhosphatasePublishingRNA-Directed DNA PolymeraseReactive Oxygen SpeciesReadingRecombinantsRecruitment ActivityRegulationRegulatory PathwayResearchResearch DesignRoleSamplingSchemeSeriesSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNASourceSpecimenSrc homology 2 domain-containing, transforming protein 1StagingStimulusSynaptophysinSystemTNFSF5 geneTestingTherapeuticTimeTissue Inhibitor of MetalloproteinasesTissue SampleTubulinTumor Necrosis Factor ReceptorTumor Necrosis Factor-alphaTumor Necrosis FactorsUnited StatesUp-RegulationVirusWorkastrogliosisautocrinebrain tissuecell growth regulationcell typechemokineclinically relevantclinically significantcytokinefrontal lobehuman MAPK14 proteinhuman NOS2A proteinin vivoinhibitor/antagonistinsightinterestmacrophagemild neurocognitive impairmentmitogen-activated protein kinase p38monocytemutantneuroinflammationneuronal survivalneuroprotectionneurotoxicitynovelpublic health relevanceresearch studyresponsetool

项目摘要

项目成果

Anuja Ghorpade的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):目前,全世界有近3500万人感染HIV-1。HIV-1相关性痴呆(HAD)沿着轻度神经认知障碍和无症状神经认知损害包括HIV相关性神经认知障碍(HAND)。与较轻度形式的HIV脑炎相关的炎症显示在炎症区域存在活化的小胶质细胞、反应性星形胶质细胞增生和神经元损伤。几年前,我们开始对与神经胶质激活相关的潜在机制及其在神经艾滋病中的贡献进行新的研究。在初步实验中使用原代人神经胶质细胞,并且CXCL 8是在活化的星形胶质细胞和其他神经细胞中上调的关键分子之一。重要的是,CXCL 8在暴露于HIV-1相关神经毒素的培养的人类神经元中具有神经保护作用。这一观察结果的生物学相关性得到了进一步证实,因为与年龄匹配的对照组相比,HIV-1感染的脑组织显示出更高的CXCL 8水平。我们认为CXCL 8在HIV-1 CNS感染的细胞间相互作用中起着关键的调节作用。小胶质细胞感染和活化导致IL-12的上调。IL-12是星形胶质细胞的典型炎症刺激物,可增强CNS中星形胶质细胞产生CXCL 8。CXCL 8进一步招募小胶质细胞并调节小胶质细胞活化和HIV-1感染。总之,这些事件最终可能导致CXCL 8介导的直接或间接神经保护。为了这些目的,我们将解决以下具体问题:CXCL 8是如何调节激活的星形胶质细胞在HAD和参与的机制是什么?(Aim 1)胶质细胞CXCL 8如何调节小胶质细胞的募集、激活和感染?(Aim 2)CXCL 8如何在HAD过程中调节神经元的存活和/或功能?(Aim 3)在目标1中,人脑组织标本和原代人神经细胞将用于描绘HAD中CXCL 8谱并鉴定HAD中CXCL 8的细胞来源。将原代人神经细胞暴露于HAD特异性刺激,并评价CXCL 8调节。将在星形胶质细胞中研究参与IL-8调节的细胞内信号传导途径,特别是NF-:B、p38 MAPK和/或SHP 2。将在目的2中评价活化的星形胶质细胞和小胶质细胞之间通过CXCL 8介导的细胞间相互作用在调节小胶质细胞活化、募集和HIV-1感染中的作用。CXCL 8神经保护的机制和随后的信号转导,特别是通过Akt/PKB,ERK 1/2,Bcl-2和Bax和TNF受体在这些神经保护事件中的作用将使用原代人类神经元研究目标3。总之,本申请中提出的研究将提供关于CXCL 8介导的胶质细胞串扰和神经发病机制的新数据,并导致对具有基础和临床意义的胶质细胞炎症反应调节的新见解。公共卫生相关性:迄今为止,全世界有近6000万人感染了人类免疫缺陷病毒-1。HIV-1相关性神经认知障碍(HAND)是HIV-1感染后的一种重要神经系统并发症,由HIV-1相关性痴呆(HAD)沿着其他神经认知障碍组成。据估计,在发达国家,如美国,10-15%的HIV血清阳性(HIV+)患者进展为HAD,尽管有高度活性的抗逆转录病毒治疗。神经胶质炎症是参与这种疾病的重要机制,该提案的数据将更好地了解激活的神经胶质对HIV-1痴呆的具体机制贡献,并对神经保护具有更广泛的意义。
英文摘要
DESCRIPTION (provided by applicant): Currently, almost 35 million people live with HIV-1 infection worldwide. HIV-1-associated dementia (HAD) along with mild neurocognitive disorder and asymptomatic neurocognitive impairment comprises the HIV- associated neurocognitive disorder (HAND). Inflammation associated with milder forms of HIV encephalitis shows presence of activated microglia, reactive astrogliosis and neuronal injury in areas of inflammation. A few years ago, we began novel investigations into the potential mechanisms associated with glial activation & their contribution in neuro-AIDS. Primary human glial cells were used in preliminary experiments and CXCL8 was among the key molecules upregulated in activated astrocytes and other neural cells. Importantly, CXCL8 was neuroprotective in cultured human neurons exposed to HIV-1-related neurotoxins. Biological relevance of this observation was further confirmed as HIV-1-infected brain tissues demonstrated greater CXCL8 levels as compared to age-matched controls. We propose that CXCL8 plays a key regulatory role in the intercellular interactions in HIV-1 CNS infection. Microglial infection and activation leads to upregulation of IL-12. IL-12, a prototypical inflammatory stimulus for astrocytes, enhances CXCL8 production by astrocytes in CNS. CXCL8 further recruits microglia and regulates microglial activation and HIV-1 infection. Taken together, ultimately these events may lead to CXCL8-mediated direct or indirect neuroprotection. To these ends, we will address the following specific questions: How is CXCL8 regulated in activated astrocytes in HAD and what mechanisms are involved? (Aim 1) How does glial CXCL8 regulate microglial recruitment, activation and infection? (Aim 2) How does CXCL8 regulate neuronal survival and/or function during the process of HAD? (Aim 3) In Aim 1, human brain tissue specimens and primary human neural cells will be utilized to delineate CXCL8 profiles and to identify the cellular sources for CXCL8 in HAD. Primary human neural cells will be exposed to HAD-specific stimuli and CXCL8 regulation will be evaluated. The intracellular signaling pathways involved in IL-8 regulation, specifically, NF-:B, p38MAPK and/or SHP2 will be studied in astrocytes. The role of intercellular interactions between activated astrocytes and microglia via CXCL8-mediated in regulation of microglial activation, recruitment and HIV-1 infection will be evaluated in Aim 2. The mechanisms of CXCL8 neuroprotection and the ensuing signal transduction specifically through Akt/PKB, ERK1/2, Bcl-2 and Bax and the role of TNF receptors in these neuroprotective events will be investigated using primary human neurons in Aim 3. Taken together, the studies proposed in this application will provide novel data about CXCL8-mediated glial cross-talk and neuropathogenesis and lead to novel insights into regulation of glial inflammatory responses that have both basic and clinical significance. PUBLIC HEALTH RELEVANCE: To date, almost 60 million people have been infected worldwide with the human immunodeficiency virus -1. HIV-associated neurocognitive disorder (HAND) that consists of HIV-1-associated dementia (HAD) along with other neurocognitive impairments, is an important neurological complication of HIV-1 infection. An estimated 10-15% of HIV-seropositive (HIV+) patients progress to HAD in developed worlds such as the United States, despite highly active antiretroviral therapy. Glial inflammation is an important mechanism involved in this disease and the data from this proposal will provide a better understanding of the specific mechanistic contributions of activated glia to HIV-1-dementia and have broader implications for neuroprotection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting latent HIV Astroglial Reservoirs without Reactivation
Astrocyte-TAAR1 & METH in HAND
Health Disparities & sCD40L: Novel Biomarkers for HIV-1 Disease Progression
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury
  • 批准号:
    8448346
  • 项目类别:
  • 资助金额:
    $37.54万
  • 财政年份:
    2009
  • 负责人:
    Anuja Ghorpade
  • 依托单位:
海外基金